| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Grant Julie Papanek is a Director at Protagonist Therapeutics, Inc with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $201.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Director | Sell | 5,000 | $23.82 | $119,107.50 | -1.1% | -10.8% | -41.3% | |
| Sep 1, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Director | Sell | 5,000 | $23.27 | $116,358.38 | -0.6% | -10.6% | -41.2% | |
| Aug 5, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Director | Sell | 10,000 | $20.00 | $200,004.00 | -1.1% | -18.1% | -45.4% | |
| Jul 18, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Director | Sell | 2,600 | $20.00 | $52,001.04 | -0.6% | +8.5% | -36.3% | |
| Jul 8, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Director | Sell | 1,242 | $20.00 | $24,840.00 | -0.3% | +4.6% | -40.9% | |
| Jul 5, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Director | Sell | 1,800 | $20.00 | $36,000.00 | -0.2% | +3.9% | -39.0% | |
| Jun 1, 2021 | DAWN Day One Biopharmaceuticals, Inc. | Director | Buy | 13,000 | $16.00 | $208,000.00 | +0.1% | +28.7% | -69.2% | |
| Aug 16, 2016 | PTGX Protagonist Therapeutics, Inc | Director | Buy | 583,333 | $12.00 | $6,999,996.00 | +31.2% | - | - |